妇科恶性肿瘤保器官的临床诊治

Strategies for organ-preserving treatment of gynecological malignancies

摘要

近年来,随着妇科恶性肿瘤患者对生活质量要求的提高,越来越多的患者渴望在治疗中保留器官、功能及生育能力.如何在确保疗效的同时,满足患者这方面的期望,成为妇科肿瘤医生关注的重要课题.本综述涵盖了宫颈癌、子宫内膜癌、卵巢癌等妇科常见的五种恶性肿瘤的临床诊治,以期最大限度的保留器官和功能,减少对正常组织的损伤,提升患者的生活质量.

Abstract

In recent years, with the increasing demands for quality of life among patients with gynecological malignancies, more and more patients are eager to preserve their organs, functions, and fertility during treatment. Balancing effective treatment with meeting these patient expectations has become a key concern for gynecologic oncologists. This review covers the clinical diagnosis and treatment of five common gynecologic malignancies, including cervical cancer, endometrial cancer, and ovarian cancer, with the aim of maximizing organ and functional preservation, minimizing damage to healthy tissues, and enhancing patients' quality of life.

关键词

妇科恶性肿瘤 / 保器官治疗 / 生育力保护 / 多学科综合治疗协作组

Key words

gynecological malignancy / organ preservation therapy / fertility preservation / multidisciplinary treatment collaboration

参考文献

[1] 中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)宫颈癌诊疗指南2023[M]. 北京 人民卫生出版社, 2023.

[2] Manganaro L, Lakhman Y, Bharwani N, et al. Staging, recurrence and follow-up of uterine cervical cancer using MRI: updated guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018[J]. Eur Radiol, 2021, 31(10): 7802-7816.

[3] Morice P, Scambia G, Abu-Rustum N R, et al. Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE.[J]. Lancet Oncol, 2024, 25(11): e602-e610.

[4] Fricová L, Kommoss S, Scambia G, et al. Reproductive outcomes after fertility-sparing surgery for cervical cancer-results of the multicenter FERTISS study[J]. Gynecol Oncol, 2024, 190(1): 179-185.

[5] Liu C K, Huang K G, Chen M J, et al. The current trend of fertility preservation in patients with cervical cancer[J]. Gynecol Minim Invasive Ther, 2024, 13(1): 4-9.

[6] Schmeler K M, Pareja R, Lopez Blanco A, et al. ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer[J]. Int J Gynecol Cancer, 2021, 31(10): 1317-1325.

[7] 中国抗癌协会宫颈癌专业委员会. 早期子宫颈癌保留生育功能诊治指南(2025年版)[J]. 中国实用妇科与产科杂志, 2025, 41(1): 66-75.

[8] 章易琳, 韩伶俐, 倪观太. 预防性McDonald环扎与Shirodkar环扎对早产高危孕妇的临床效果比较[J]. 中国妇幼健康研究, 2022, 33(10): 108-112.

[9] Laios A, Otify M, Papadopoulou A, et al. Outcomes of ovarian transposition in cervical cancer; an updated meta-analysis[J]. BMC Womens Health, 2022, 22(1): 305.

[10] 孔北华, 马丁, 段涛. 妇产科学[M].第10版. 北京: 人民卫生出版社, 2024.

[11] Chen J, Cao D, Yang J, et al. Oncological and reproductive outcomes for gonadotropin-releasing hormone agonist combined with aromatase inhibitors or levonorgestrel-releasing intra-uterine system in women with endometrial cancer or atypical endometrial hyperplasia[J]. Int J Gynecol Cancer, 2022, 32(12): 1561-1567.

[12] 周蓉, 鹿群, 刘国莉, 等. 早期子宫内膜癌保留生育功能治疗专家共识(2022年版)[J]. 中国妇产科临床杂志, 2023, 24(2): 215-219.

[13] 王世宣. 女性恶性肿瘤患者化疗时卵巢损伤的防治策略专家共识[J]. 实用妇产科杂志, 2020, 36(9): 667-670.

[14] Laufer J, Scasso S, Kimelman D, et al. Uterine transposition in a patient with vulvar cancer[J]. Gynecol Oncol Rep, 2024, 52: 101337.

基金资助

国家自然科学基金项目(82203410)